Audio transcript NINA MOINI: Starting next week, Medicare will begin a new pilot program that will allow some users to access popular weight loss drugs, GLP-1s, at a reduced cost
The most frequently reported adverse effects involve gastrointestinal symptoms, which typically emerge during the initial days to weeks of supplementation as the gut microbiome adjusts to the introduced bacterial strains
Will microdosing still curb appetite
The decision to prescribe Wegovy to someone with epilepsy requires careful consideration of several factors, including the type and severity of epilepsy, current seizure control, the specific anti-epileptic medications being taken, and overall health status
You might also experience reemergence of food noise, or intrusive thoughts about food and increased appetite, says Kushner
For early to moderate type 2 diabetes, GLP-1 medications are increasingly preferred due to weight loss benefits, lower hypoglycemia risk, and cardiovascular protection